Intellia Therapeutics, Inc. (NTLA)

Last Closing Price: 11.60 (2025-08-28)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Intellia Therapeutics, Inc. (NTLA) had Net Income of $-101.25M for the most recently reported fiscal quarter, ending 2025-06-30.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
$14.24M
Net Income
$-101.25M
--
$14.24M
$124.24M
$-110.00M
$8.74M
$-101.25M
$-101.25M
$-101.25M
$-101.25M
$-101.25M
$-101.25M
$-110.00M
$-107.52M
103.73M
103.73M
$-0.98
$-0.98
Balance Sheet Financials
$495.94M
$22.81M
$402.95M
$898.89M
$95.50M
--
$88.14M
$183.64M
$715.26M
$715.25M
$715.25M
105.33M
Cash Flow Statement Financials
$-248.55M
$201.24M
$14.65M
$202.79M
$170.12M
$-32.66M
$43.88M
--
--
Fundamental Metrics & Ratios
5.19
--
--
--
--
100.00%
-772.17%
-772.17%
--
-710.81%
-710.81%
$-249.53M
--
--
--
0.02
--
1.25
71.73
-14.16%
-14.16%
-11.26%
-14.16%
$6.79
$-2.41
$-2.40